Yoshiyuki Katsuta

Suggest Changes
Learn More
We clarified the reconstructed 3D dose difference between two different commercial software programs (Mobius3D v2.0 and PerFRACTION v1.6.4). Five prostate cancer patients treated with IMRT (74 Gy/37(More)
  • 1